SG10201404895XA - Diagnosis - Google Patents

Diagnosis

Info

Publication number
SG10201404895XA
SG10201404895XA SG10201404895XA SG10201404895XA SG10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA
Authority
SG
Singapore
Prior art keywords
diagnosis
Prior art date
Application number
SG10201404895XA
Other languages
English (en)
Inventor
Zeng Qi
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG10201404895XA priority Critical patent/SG10201404895XA/en
Priority to SG11201701076TA priority patent/SG11201701076TA/en
Priority to CN201580052886.7A priority patent/CN106716132A/zh
Priority to JP2017507713A priority patent/JP2017526916A/ja
Priority to EP15831971.5A priority patent/EP3189333A4/en
Priority to US15/503,155 priority patent/US20170234880A1/en
Priority to PCT/SG2015/050259 priority patent/WO2016024918A1/en
Publication of SG10201404895XA publication Critical patent/SG10201404895XA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG10201404895XA 2014-08-13 2014-08-13 Diagnosis SG10201404895XA (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis
SG11201701076TA SG11201701076TA (en) 2014-08-13 2015-08-13 Diagnosis of cancer
CN201580052886.7A CN106716132A (zh) 2014-08-13 2015-08-13 癌症的诊断
JP2017507713A JP2017526916A (ja) 2014-08-13 2015-08-13 癌の診断
EP15831971.5A EP3189333A4 (en) 2014-08-13 2015-08-13 Diagnosis of cancer
US15/503,155 US20170234880A1 (en) 2014-08-13 2015-08-13 Diagnosis of cancer
PCT/SG2015/050259 WO2016024918A1 (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis

Publications (1)

Publication Number Publication Date
SG10201404895XA true SG10201404895XA (en) 2016-03-30

Family

ID=55304429

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis
SG11201701076TA SG11201701076TA (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201701076TA SG11201701076TA (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Country Status (6)

Country Link
US (1) US20170234880A1 (enExample)
EP (1) EP3189333A4 (enExample)
JP (1) JP2017526916A (enExample)
CN (1) CN106716132A (enExample)
SG (2) SG10201404895XA (enExample)
WO (1) WO2016024918A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10874610B2 (en) 2016-10-19 2020-12-29 Northwestern University Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer
CN107058556A (zh) * 2017-05-09 2017-08-18 大连海事大学 一种用于评估硫丹促癌风险的方法
CN110613727B (zh) * 2017-12-11 2022-06-21 浙江大学 NK细胞外泌体hsa-miR-9502在抗菌中的应用
CN110531082A (zh) * 2018-05-25 2019-12-03 国家纳米科学中心 用于乳腺癌检测及分子分型的外泌体检测装置和应用
US20230266323A1 (en) * 2020-08-06 2023-08-24 Lsi Medience Corporation Diagnosis method for bladder cancer
CN112698033A (zh) * 2020-12-09 2021-04-23 复旦大学附属中山医院 一种血源性外泌体her2的检测方法及其应用
CN118376789B (zh) * 2024-06-25 2024-09-13 南昌大学第一附属医院 一种用于诊断肺癌的检测试剂盒及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1848742A1 (en) * 2005-01-28 2007-10-31 Attogen, Inc. Anti-prl-3 antibodies and methods of use thereof
DK3360571T3 (da) * 2007-05-03 2021-01-04 Agency For Science Tech And Research Astarstar Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid
CN107254538A (zh) * 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
CN108434440B (zh) * 2011-09-06 2022-08-23 新加坡科技研究局 多肽疫苗

Also Published As

Publication number Publication date
WO2016024918A1 (en) 2016-02-18
JP2017526916A (ja) 2017-09-14
EP3189333A4 (en) 2018-04-18
SG11201701076TA (en) 2017-03-30
EP3189333A1 (en) 2017-07-12
CN106716132A (zh) 2017-05-24
US20170234880A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
AU361515S (en) Dishrack
PT3094237T (pt) Eletrocardiógrafo
AU362944S (en) Lapboard
IL250017A0 (en) Eye examination devices
DK3191586T3 (en) Cellobiosephosphorylase
SG10201404895XA (en) Diagnosis
DK3178931T3 (en) Anti-orai1-antistof
PL3190964T3 (pl) Spirometr
GB201409851D0 (en) Diagnostic method
DK3145380T3 (en) Toiletventilationssystem
GB201504297D0 (en) Diagnosis
GB201408875D0 (en) Diagnostic method
GB201406616D0 (en) Imaging
GB201412131D0 (en) Diagnostics
GB201414421D0 (en) Techflush unit
GB201516557D0 (en) Diagnosis
AU5585P (en) Lanutah Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi